Cannabinor
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Cannabinor (PRS-211,375) is a drug which acts as a potent and selective cannabinoid CB 2 receptor agonist. It is classed as a "nonclassical" cannabinoid with a chemical structure similar to that of cannabidiol. It has a CB 2 affinity of 17.4 nM vs 5,585 nM at CB 1 , giving it over 300× selectivity for CB 2 . It showed analgesic effects in animal studies especially in models of neuropathic pain, but failed in Phase IIb human clinical trials due to lack of efficacy.
Cannabinor (PRS-211,375) is a drug which acts as a potent and selective cannabinoid CB 2 receptor agonist. It is classed as a "nonclassical" cannabinoid with a chemical structure similar to that of cannabidiol. It has a CB 2 affinity of 17.4 nM vs 5,585 nM at CB 1 , giving it over 300× selectivity for CB 2 . It showed analgesic effects in animal studies especially in models of neuropathic pain, but failed in Phase IIb human clinical trials due to lack of efficacy.
See also
Cannabicyclohexanol O-1871
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330136523 under CC BY-SA 4.0; modifications have been made.